D
Dirk Verellen
Researcher at University of Antwerp
Publications - 26
Citations - 821
Dirk Verellen is an academic researcher from University of Antwerp. The author has contributed to research in topics: Breast cancer & Dosimetry. The author has an hindex of 7, co-authored 26 publications receiving 330 citations.
Papers
More filters
Journal ArticleDOI
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.
Matthias Guckenberger,Yolande Lievens,Angelique B Bouma,Laurence Collette,Andre Dekker,Nandita M. deSouza,Anne-Marie C. Dingemans,Anne-Marie C. Dingemans,Beatrice Fournier,Coen W. Hurkmans,Frédéric Lecouvet,Icro Meattini,Alejandra Méndez Romero,Umberto Ricardi,Nicola S. Russell,Daniel Schanne,Marta Scorsetti,Bertrand Tombal,Dirk Verellen,Christine Verfaillie,Piet Ost +20 more
TL;DR: 20 international experts including 19 members of the European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer OligoCare project developed a comprehensive system for characterisation and classification of oligometastatic disease.
Journal ArticleDOI
Overview of artificial intelligence-based applications in radiotherapy : Recommendations for implementation and quality assurance
Liesbeth Vandewinckele,Michaël Claessens,Anna M. Dinkla,Charlotte L. Brouwer,Wouter Crijns,Dirk Verellen,Wouter van Elmpt +6 more
TL;DR: Generally applicable recommendations on implementation and quality assurance of AI models are presented for commonly used applications in radiotherapy such as auto-segmentation, automated treatment planning and synthetic computed tomography.
Journal ArticleDOI
Machine learning applications in radiation oncology: Current use and needs to support clinical implementation
Charlotte L. Brouwer,Anna M. Dinkla,Liesbeth Vandewinckele,Wouter Crijns,Michaël Claessens,Dirk Verellen,Wouter van Elmpt +6 more
TL;DR: Besides the need for (implementation) guidelines, training of medical physicists and larger databases containing multicentre data was found to be the top priority to accommodate the further introduction of ML in clinical practice.
Journal ArticleDOI
Radiation Oncology. Optimal Health for All, Together. ESTRO vision, 2030.
Yolande Lievens,Umberto Ricardi,Philip Poortmans,Dirk Verellen,Chiara Gasparotto,Christine Verfaillie,Alessandro J. Cortese +6 more
TL;DR: The European Society of Radiation oncology (ESDO) as mentioned in this paper has developed strategic priorities for the coming years, focusing on translating science and evidence into practice, supporting professional development in the discipline, further strengthening the Society and embracing an active policy-role.
Journal ArticleDOI
Evaluation of automated pre-treatment and transit in-vivo dosimetry in radiotherapy using empirically determined parameters.
TL;DR: In-vivo transit dosimetry efficiently reveals a wide variety of deviations and shows potential to serve as a base for adaptive planning.